Daniel Bourquin

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

Felix Hasler, Daniel Bourquin, Rudolf Brenneisen et al. · Pharmaceutica Acta Helvetiae · 1997 · 223 citations

4-Hydroxyindole-3-acetic Acid, Medicine, Intravenous Psilocybin +6

Analysis of 3,4-Methylenedioxymethamphetamine (MDMA) and its Metabolites in Plasma and Urine by HPLC-DAD and GC-MS

H. J. Helmlin, K. Bracher, Daniel Bourquin et al. · Journal of Analytical Toxicology · 1996 · 160 citations

Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man

Felix Hasler, Daniel Bourquin, Rudolf Brenneisen et al. · Journal of Pharmaceutical and Biomedical Analysis · 2002 · 98 citations

Renal Excretion Profiles, Urology, Medicine +4

Determination of morphine-3-glucuronide in human urine by capillary zone electrophoresis and micellar electrokinetic capillary chromatography

Paul Wernly, Wolfgang Thormann, Daniel Bourquin et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1993 · 51 citations

Human Urine, Capillary Zone Electrophoresis, Medicine +8

Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program

E. Gyr, Rudolf Brenneisen, Daniel Bourquin et al. · International Journal of Clinical Pharmacology and Therapeutics · 2000 · 49 citations

Two-patient Pilot Study, Heroin-assisted Treatment Program, Rectal Diacetylmorphine +17